| Literature DB >> 19519879 |
Alexis C Edwards1, Liesbeth Zwarts, Akihiko Yamamoto, Patrick Callaerts, Trudy F C Mackay.
Abstract
BACKGROUND: Aggressive behavior in animals is important for survival and reproduction. Identifying the underlying genes and environmental contexts that affect aggressive behavior is important for understanding the evolutionary forces that maintain variation for aggressive behavior in natural populations, and to develop therapeutic interventions to modulate extreme levels of aggressive behavior in humans. While the role of neurotransmitters and a few other molecules in mediating and modulating levels of aggression is well established, it is likely that many additional genetic pathways remain undiscovered. Drosophila melanogaster has recently been established as an excellent model organism for studying the genetic basis of aggressive behavior. Here, we present the results of a screen of 170 Drosophila P-element insertional mutations for quantitative differences in aggressive behavior from their co-isogenic control line.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19519879 PMCID: PMC2707370 DOI: 10.1186/1741-7007-7-29
Source DB: PubMed Journal: BMC Biol ISSN: 1741-7007 Impact factor: 7.431
P{GT1} lines with aberrant aggressive behavior
| BG00151 | 23A3–23A3 | 16.35** | 0.96 | Unknown | ||||||
| BG00336 | 64B13–64B17 | 6.1*** | -1.45 | ↓ | Axon guidance; regulation of Rho protein signal transduction | |||||
| BG00372 | 20A1-20A1 | 17.2*** | 0.94 | ↑ | Unknown | |||||
| BG00375 | 99B8-99B8 | 14.8** | 0.53 | ↑ | ↓ | Odorant binding; autophagic cell death; transport | ||||
| BG00376† | 1E4-1E4 | 18.45*** | 1.16 | ↑ | ↑ | ↓ | Unknown | |||
| BG00386 | 83A6–83A7 | 20.65*** | 1.53 | ↓ | Long-term memory; olfactory learning; calcium-mediated signaling; nerve-nerve synaptic transmission; nervous system development | |||||
| BG00670 | 17F3-18A2 | 13.35** | 0.28 | ↑ | Unknown | |||||
| BG00735 | 78A5-78B1 | 16.25*** | 0.78 | ↑ | Central nervous system development; guanyl-nucleotide exchange factor activity | |||||
| BG00986† | 61C9-61C9 | 7.05*** | -0.90 | ↑ | ↓ | ↑ | ↓ | Nervous system development | ||
| BG01011 | 62E4–62E5 | 17.2*** | 0.69 | ↓ | ↑ | ↑ | Phosphopantetheine binding | |||
| BG01043 | 58D3-58D3 | 18.0* | 0.91 | ATP binding; transmembrane receptor protein tyrosine phosphatase signaling pathway | ||||||
| BG01046 | 2B16-2B16 | 7.9*** | -0.60 | ↑ | ↓ | ↓ | Unknown | |||
| BG01130 | 64C8–64C11 | 16.55*** | 0.86 | ↑ | ↓ | mRNA processing; gravitaxis | ||||
| BG01214† | 65D4–65D5 | 17.1*** | 0.93 | ↑ | ↓ | Cell communication; signal transduction; transmembrane receptor protein tyrosine kinase signaling pathway | ||||
| BG01215 | 59F6–59F7 | 8.7** | -0.48 | ↑ | ↓ | ↓ | Regulation of progression through cell cycle; cell cycle arrest | |||
| BG01299† | 5C7-5C7 | 3.6*** | -1.75 | ↓ | ↓ | structural constituent of cytoskeleton; ATP binding; protein binding | ||||
| BG01354 | 43E5–43E7 | 18.55** | 1.01 | ↑ | Zinc ion binding | |||||
| BG01402 | 61C7-61C7 | 15.55*** | 0.68 | ↓ | ↓ | Unknown | ||||
| BG01433 | 28B1–28B2 | 16.75** | 0.60 | ↓ | ↓ | Unknown | ||||
| BG01469† | 3B4-3B4 | 7.9*** | -0.65 | ↓ | ↓ | t-SNARE activity; neurotransmitter secretion; vesicle-mediated transport; synaptic vesicle docking during exocytosis | ||||
| BG01491 | 100D1-100D1 | 14.45* | 0.48 | ↑ | ↓ | Zinc ion binding; peripheral nervous system development; transmission of nerve impulse | ||||
| BG01498 | 11B7-11B7 | 8.85* | -0.43 | ↑ | ↓ | Receptor signaling protein serine/threonine kinase activity; ATP binding | ||||
| BG01536 | 17C3–17C4 | 7.25*** | -0.60 | ↑ | ↓ | ↓ | Zinc ion binding; locomotory behavior; response to cocaine; regulation of metabolism | |||
| BG01566 | 33D3–33D5 | 6.75*** | -0.75 | Negative regulation of oskar mRNA translation | ||||||
| BG01596† | 1A1-1A1 | 19.55*** | 1.74 | ↓ | ↑ | ↑ | ↓ | Metabolism | ||
| BG01654 | 16B4-16B4 | 9.55** | -0.57 | ↓ | ↑ | Sodium channel activity | ||||
| BG01662 | 65A8–65A9 | 15.55** | 0.68 | ↑ | ↓ | Receptor binding; locomotion; central nervous system development | ||||
| BG01683† | 15A3-15A3 | 7.65*** | -0.66 | ↓ | ↓ | Unknown | ||||
| BG01693 | 7C3–7C4 | 4.5*** | -1.11 | ↓ | ↑ | ↓ | RNA helicase activity; nucleic acid binding; ATP binding; ATP-dependent helicase activity | |||
| BG01713 | 95E1-95E1 | 8.9** | -0.50 | ↓ | Translation initiation | |||||
| BG01733 | 68C1–68C2 | 14.55* | 0.51 | ↑ | ↓ | ↓ | Unknown | |||
| BG01757 | 37B1-37B1 | 12.75* | 0.50 | ↓ | Defense response; polysaccharide metabolism; response to toxin; steroid metabolism | |||||
| BG01765 | 34C1-34C1 | 8.35** | -0.70 | ↓ | Transmembrane receptor activity; signal transduction; Toll signaling pathway | |||||
| BG01893 | 90B4-90B4 | 7.2* | -0.51 | ↑ | ↓ | ↓ | Transcription cofactor activity; nucleic acid binding; zinc ion binding | |||
| BG01900 | 85F10-85F10 | 6.6** | -0.62 | ↑ | ↓ | ↓ | microRNA | |||
| BG01909 | 25C6-25C6 | 21.45*** | 2.27 | ↓ | ↓ | ↑ | ↓ | Unknown | ||
| BG01912† | 89A1–89A2 | 17.3*** | 0.85 | ↑ | ↓ | Learning and/or memory; olfactory learning | ||||
| BG01916 | 35B2-35B2 | 13.65** | 0.36 | ↑ | ↓ | Zinc ion binding | ||||
| BG01949 | 11B16–11B16 | 16.2* | 0.57 | ↓ | Purine base metabolism; 'de novo' IMP biosynthesis | |||||
| BG02019 | 25F4–25F5 | 13.3** | 0.60 | Transferase activity | ||||||
| BG02022 | 2R | 7.15*** | -0.91 | ↓ | ↑ | Unknown | ||||
| BG02077 | 25B9-25C1 | 9.0* | -0.65 | ↑ | ↓ | ↓ | Receptor signaling protein activity; calcium ion binding | |||
| BG02081 | 25B9-25C1 | 16.6*** | 1.19 | ↓ | ↑ | Receptor signaling protein activity; calcium ion binding | ||||
| BG02095† | 24D4–24D6 | 14.8** | 0.68 | ↑ | Epidermal growth factor receptor signaling pathway; negative regulation of neurogenesis; sensory organ development | |||||
| BG02128 | 12E3–12E5 | 5.55*** | -0.86 | ↓ | ↓ | ATP-dependent RNA helicase activity; ATP-dependent helicase activity; ATP binding | ||||
| BG02188 | 85E4-85E4 | 15.8*** | 0.56 | ↑ | Intracellular protein transport | |||||
| BG02217 | 58E4–58E8 | 4.6*** | -0.99 | ↓ | ↓ | Wing vein morphogenesis | ||||
| BG02276 | 88C10-88C10 | 10.95* | 0.44 | ↑ | Unknown | |||||
| BG02377 | 54B16-54B16 | 4.2** | -0.56 | ↓/↑ | Unknown | |||||
| BG02420 | 68E1-68E1 | 3.85** | -0.61 | ↑ | Cholesterol metabolism; electron transport; fatty acid desaturation | |||||
| BG02470 | 53E4-53E4 | 7.6* | -0.52 | ↓ | ↓ | ↑ | Unknown | |||
| BG02495 | 11B16-11B16 | 13.35* | 0.33 | ↑ | ↓ | Purine base metabolism; 'de novo' IMP biosynthesis | ||||
| BG02501 | 47A11–47A13 | 7.9* | -0.61 | ↑ | Axon guidance; axonogenesis; transmission of nerve impulse | |||||
| BG02522 | 16C1–16C8 | 6.1*** | -0.80 | ↓ | ↑ | Ras GTPase activator activity; receptor binding; G-protein coupled receptor protein signaling pathway; | ||||
| BG02523 | 64C12–64C13 | 7.95*** | -0.59 | ↑ | Unknown | |||||
| BG02539 | 28E3–28E5 | 15.5** | -0.58 | ↑ | ↓ | Spermatid development | ||||
| BG02542 | 85C2–85C3 | 11.35* | -0.60 | ↑ | Ubiquitin-protein ligase activity; protein binding; zinc ion binding; nervous system development; sensory organ development; regulation of Notch signaling pathway | |||||
| BG02644 | 57E6-57E6 | 12.0** | 0.59 | ↑ | Calcium ion binding; protein folding | |||||
| BG02731 | 47A11–47A13 | 13.6** | 0.63 | ↓ | Axon guidance; axonogenesis; Transmission of nerve impulse | |||||
MAS = Mean Aggression Score. Significant MAS deviations from the control line after correcting for multiple tests are indicated by asterisks. *: P < 0.05; **: P < 0.01; ***: P < 0.0001. † Indicates lines characterized in greater detail. Pleiotropic effects of the mutations are given for numbers of sensory bristles (B) [30], locomotor startle response (L) [34]; olfactory avoidance behavior (O) [33]; male 24-hour sleep (Sl) [32] and male starvation stress resistance (St) [31]. The arrows indicate significant positive (↑) and negative (↓) deviations from the control.
Figure 1Distribution of mean aggression scores among .
Figure 2Gene ontologies of candidate genes with mutations associated with aggressive behavior. (A) Biological Process gene ontology categories. (B) Molecular Function gene ontology categories. The x-axis indicates the percentage of genes in each category for mutations increasing (red bars) and decreasing (blue bars) aggressive behavior.
Figure 3Correlation between mean aggression score (MAS) and locomotor reactivity in . Scores are given as a deviation from the control line. Data points in red represent lines with levels of aggressive behavior that are significantly different from the control.
Figure 4Structure of nine genes in which mutations affect male aggressive behavior. All genes are oriented 5' to 3', with boxes indicating exons and solid lines indicating introns. Dashed lines represent 5' putative promoter regions. Solid triangles indicate the location of the P-element insertion, with the direction of the triangle indicating the orientation of the insertion.
Figure 5Mean aggression scores of . The mean aggression score is given as the deviation from the contemporaneously tested control line for the mutant lines and up to three revertant alleles. Blue bars indicate significantly (P < 0.05) lower levels of aggression than the control; red bars indicate higher levels of aggression than the control; and green bars indicate no significant difference in mean aggression score from the control. Hatched bars indicate imprecise revertant alleles.
Figure 6Quantitative reverse transcription-PCR analysis of candidate genes affecting aggressive behavior. Levels of mRNA for each gene (white bars) are depicted relative to the level in the co-isogenic control (black bars). mRNA levels were assessed at four developmental time periods: embryos aged 10–12 h after egg laying (E), third instar larvae (L), pupae (P), and adults (heads [H] and headless bodies [B]). Only larvae and adults could be obtained for sgl mutants. Standard errors were obtained using Ct values normalized to an internal control (Gapdh1). The significance of two-tailed Student's t-tests conducted on linearized Ct values are depicted by asterisks (*: P < 0.05; **: P < 0.01; ***: P < 0.001).
Figure 7Expression of candidate genes affecting aggressive behavior in the embryonic nervous system. The insets show the sense control probes. (A) CG32572, stage 17, ventral view: expression in the ventral cord (highlighted with dotted line). (B) CG13377, stage 14, lateral view: expression in the ventral nerve cord (arrow). (C) CG13377, stage 17, ventral view: expression in the ventral nerve cord (highlighted with dotted line). (D) ed, stage 11, lateral view: expression in the procephalic neuroblasts (arrow) and the neuroblasts forming the ventral nerve cord (arrowheads). (E) emc, stage 14, lateral view: expression in the ventral nerve cord (arrow) and the brain (asterisk). (F) emc, stage 17, ventral view: expression in the ventral nerve cord (highlighted with dotted line). (G) Syx4, stage 13, lateral view: expression in the ventral nerve cord (arrow) and the brain (asterisk). (H) Act5C, stage 16, ventral view: expression in the ventral nerve cord (highlighted with dotted line).
Mushroom body measurements
| 6.03 (0.09) | 0.6925 (0.0170) | 4.28 (0.03) | 0.7901 (0.0236) | |
| 6.35 (0.13)* | 0.6648 (0.0185) | 4.18 (0.04) | 0.7746 (0.0282) | |
| 6.07 (0.13) | 0.8372 (0.0323)*** | 4.26 (0.06) | 0.8866 (0.0303)* | |
| 5.99 (0.12)*** | 0.8036 (0.0222) | 4.22 (0.04) | 0.8273 (0.0342) | |
| 6.56 (0.09)*** | 0.8218 (0.0169)*** | 4.23 (0.04) | 0.8085 (0.0345) | |
| 5.99 (0.16) | 0.8330 (0.0299)*** | 4.09 (0.08)* | 0.8683 (0.0389) | |
| 6.23 (0.17) | 0.7174 (0.0216) | 4.29 (0.05) | 0.8622 (0.0300) | |
| 6.12 (0.08) | 0.8070 (0.0230)*** | 4.15 (0.05)* | 0.8729 (0.0281)* | |
| 5.60 (0.13)** | 0.7631 (0.0214)* | 4.25 (0.07) | 0.8263 (0.0312) | |
| 5.94 (0.14) | 0.7044 (0.0170) | 4.13 (0.05)* | 0.8504 (0.0194) | |
Measurements of the length and width of alpha and beta lobes (± SE) for Canton S B (the control line) and mutant lines associated with increased or decreased levels of aggression. Measurements are standardized to overall brain size. *: P < 0.05; **: P < 0.01; ***: P < 0.001.
Figure 8Gross morphological defects in the mushroom bodies in mutations of candidate genes affecting aggressive behavior. A-H: anti-fasciclin 2 staining of adult brains using the 1D4 monoclonal antibody. Defects are indicated by the white arrows. (A) Canton S B control line. α, alpha lobes of mushroom bodies; β, beta lobes of mushroom bodies. (B) Missing beta lobe in CG32572 mutation. (C) Misrouting of some of the alpha lobe axons leads to thicker beta lobes and thinner alpha lobes in ed mutation. (D) Shorter alpha lobe in emc mutation. (E) Overextension resulting in fusion of the beta lobes in sgl mutation. (F) Alpha lobe tip defect resulting in enlargement of the tip in CG13377 mutation.